Filing Details
CG Oncology, Inc. (NASDAQ:CGON) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 06, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:CGON
CG Oncology, Inc. (CGON) Files Quarterly Report for Q0
Filing Details CG Oncology, Inc. (NASDAQ:CGON) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 06, 2026. The Healthcare company…
Market Context
CG Oncology, Inc.'s stock currently trades at $74.85 with a market capitalization of $3.1B.
The 10-Q provides CG Oncology, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for CG Oncology, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CGON Stock Page
Frequently Asked Questions
Where can I read CGON's SEC filings?
Browse all filings on our CGON SEC filings page.
What types of SEC filings does CG Oncology, Inc. file?
Public companies like CG Oncology, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.